Výsledky vyhledávání - "Liliana D Gonzalez"

High incidence of brain metastasis in young patients with lung adenocarcinoma

Autor: Gaston Martin Reinas, Alba Marin Ordoñez, Edgardo G. J. Rivarola, Monica Montiel, Maximiliano Brandon, Mariana Abal, Felipe G. Gercovich, Eduardo L. Morgenfeld, Ernesto Gil Deza, Ilene Ramirez, Liliana D Gonzalez

Publikováno v: Journal of Clinical Oncology. 38:e21677-e21677

e21677 Background: Young patients with lung cancer are unusual. This paper focuses on our experience with Young Patients (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c600b354c3a6dac725e0bee1c2e1fb9b
https://doi.org/10.1200/jco.2020.38.15_suppl.e21677

Zobrazit plný text záznamu

Vitiligo is correlated with clinical benefits in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors (ICI)

Autor: Marcelo Muino, Mariana Abal, Carlos Fernando Garcia Gerardi, Liliana D Gonzalez, Felipe G. Gercovich, Marcelo Andres Nunell, Cesar Gonzalez, Flavio Tognelli, Ernesto Gil Deza, Edgardo G. J. Rivarola, Alba Marin Ordoñez, Eduardo L. Morgenfeld, Gaston Martin Reinas

Publikováno v: Journal of Clinical Oncology. 38:e22023-e22023

e22023 Background: Use of ICI changed the treatment of Advanced Cutaneous Melanoma Patients (ACMP). This paper analyzes the evolution of ACMP who develop vitiligo during ICI treatment at Instituto Oncológico Henry Moore (IOHM). Methods: We selected

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::379055bc549c0705f922d1202c6931de
https://doi.org/10.1200/jco.2020.38.15_suppl.e22023

Zobrazit plný text záznamu

Real-world evidence: A retrospective-cohort study of castration-resistant advanced prostate cancer (CRAPC) patients treated with abiraterone 1000 mg or 250 mg

Autor: Edgardo G. J. Rivarola, Sandra L. Ares, Felipe G. Gercovich, Claudia Lorena Acuna, Ernesto Gil Deza, Liliana D Gonzalez, Cesar Gonzalez, Carlos Fernando Garcia Gerardi, Leonel Smolje, Dario Niewiadomski, Marcelo Muino, Eduardo L. Morgenfeld

Publikováno v: Journal of Clinical Oncology. 38:e19315-e19315

e19315 Background: The efficacy of Abiraterone 250 mg with food was established ten years ago (Ryan JCO 2010). Recent publications (Szmulewitz JCO 2018) have concluded that 1000 mg on an empty stomach or 250 mg with food have similar results. This pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8175d7a203ffd0c743bc169ea4a6599a
https://doi.org/10.1200/jco.2020.38.15_suppl.e19315

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání